Lykos Therapeutics was earlier this year denied approval for their MDMA formulation developed to treat post-traumatic stress disorder. The FDA advisory panel that rejected the application cited various issues as their basis, including sexual misconduct during the clinical trials, concerns about the drug’s potential for abuse, and a failure to submit data requested.
Dr. Mwango Kashoki, Parexel’s global head of regulatory strategy, explained that these challenges were a reminder that biotechnology firms aren’t exempt from stringent regulatory examination.Parexel is an international clinical research organization and biopharmaceutical services firm.
However, Kashoki adds that if one psychedelic firm could cross this goalpost, it would be easier for others to do so. To help, Parexel has developed a road map guiding psychedelic firms on how to overcome these obstacles.
So, what does the road map contain?
For starters, Parexel emphasizes the need for firms to have open channels of communication with regulators. In particular, it recommends that firms engage with regulators in the early stages of development to provide insight for the future.
Kashoki adds that ensuring appropriate doses are selected for trials is also crucial. This, she explains, is because psychedelic trials carry safety risks. Exploring different dosing regimens can also allow sponsors to choose the most effective dose that has the least side effects.
Additionally, Parexel emphasizes the need for firms to take time when selecting doses instead of relying solely on clinical data. Here, Kashoki explains that companies need to conduct appropriate early-phase assessments to explore dose response from a physiologic, pharmacodynamic, and pharmacokinetic effects perspective.
Given that blinding researchers and subjects is still one of the biggest obstacles in trials for psychedelic treatments, Parexel also recommends that trials either administer comparative drugs with similar effects in the placebo group or recruit a blinded independent party to record effectiveness and safety data. This will help reduce the potential for bias.
In the report, Dr. Kashoki notes that if these concerns and considerations are sufficiently dealt with, then there will be no reason for the FDA to not consider the approval of these psychedelic treatments.
About PsychedelicNewsWire
PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
I started at this location in 2008 working for Village Farms International growing produce. Prior to that I worked at some other greenhouses, so I’ve been in the greenhouse industry since 2000. I studied a greenhouse management course. At the time, greenhouses were expanding rapidly in the late 90s and early 2000s; the vegetable industry really picked up here in Delta, British Columbia. Today at Pure Sunfarms, we’re currently cultivating in 1.65 million square-feet of greenhouse space.
The real advantage of growing in a greenhouse in B.C. is that even though it appears that it’s raining here all the time, the absolute humidity is actually very low. You can see that from the types of plants we have – like pine trees and spruce – that are drought tolerant. Generally, the air is very dry in B.C. We can keep the rain out and use the dry air to make the greenhouse air optimal for the plants. The fact that it rains a lot here is a benefit because we’re able to collect all that rainwater to feed the plants. We collect the runoff from plants so we’re not losing the fertilizers into the environment – they’re just going back into our plants.
The other benefit to growing in a greenhouse is that a lot of the wind that comes off the ocean in the summertime has a cooling effect, so the coastal climate doesn’t have as many extremes. The supplemental light we use is for the winter, especially in flower when the plants require more energy. Once you get to May, it’s not really worth it to run the lights, because you’ll get enough sunny days in between the cloudy days.
The importance of continued experimentation
Understanding what quality you’re trying to achieve is critical. The team is very important, as is learning through experimentation. We’re not solely using mechanics to make the climate inside. We depend on the air outside a lot. We don’t have air conditioners in the greenhouse; we’re trying to use the energy from the sun as well as the air outside and the physics of the greenhouse to make the climate inside. There’s also a local climate benefit. The wind coming off the ocean tends to blow the clouds away quickly, so we have a lot more sunlight hours in this area.
Advertisement
We’re constantly experimenting. Sometimes I run mini experiments because I want to see the limitations. I have to understand the limitations and the problems, and what caused them – pushing the boundaries of what’s possible to make continuous improvements. That gives us the parameters we need to be within. From those learnings, scaling up is easily done.
Research, development and innovation
We innovate in other ways as well. We have research partnerships with Simon Fraser University (SFU) and Langara College, and a lot of those experiments, they run them, and our teams direct them.
The experiments help with innovation and problem solving. With SFU, the kinds of innovation we collaborate on are more plant-related: disease management, IPM, and water sterilization. Unlike gardening, in farming you’re often battling bacteria, fungi, viroids and viruses, so you have to build a way that you’re protected from that into your system. With Langara, the work we do is more on the secondary side, like figuring out procedures and optimizing our product and manufacturing processes.
When thinking about AI as a tool for innovation, I’m interested in reaction time; the reaction time to the changing environment outside. This high-tech greenhouse is fully controlled by a climate system. Our expertise is setting the optimal parameters, which are constantly adjusted, especially when transitioning seasons. So, in using AI, I’m most interested in speeding up reaction times to maintain the optimal climate.
Advertisement
As far as choosing new cultivars, we have a system. What I learned during my time in produce is how to best run our climate and our system; the cultivar has to work within that system. We don’t try to change the system to make the cultivar work in it. Overall, we’re phenohunting in the greenhouse, trialing as many different cultivars as possible, and then we look at how it fits in our system, all the way to processing. It has to work in our climate, and it’s got to meet the consumer’s quality expectations.
We’re fortunate that we have an in-house lab that we can use to test all aspects of what we do, including trialing new products. I think this year we’ve already grown 1,000 different cultivars. Each pheno is different, and we have this ability to quickly assess them through trial. That’s something I’ve never been able to accomplish in produce previously.
At the end of the day to achieve brand loyalty, we need consistent great quality.And that’s our job, from farm to shelf, starting with cultivation.
VP of cultivation and operations, Rob Baldwin grows high quality plants with a passionate team of growers. He is responsible for all aspects of Pure Sunfarms’ cultivation and greenhouse operations, and continues to showcase world-class growing capabilities.
Health Canada recently sent a memo to provincial colleges of physicians and surgeons advising them that it may contact health care practitioners to ask for evidence to support the amount of cannabis they have authorized for their patients.
The memo includes information highlighting the regulator’s ongoing efforts since 2019 to address authorizations of large amounts of cannabis several times over the industry average.
Reads the document, in part: “In an effort to facilitate the application process for patients, we would like to take this opportunity to advise you that the Department may contact health care practitioners to ask for evidence to support the amount of cannabis that they have authorized for their patient. This information may include data, references, or resources to support the authorized daily quantity. This evidence will support the Department in assessing the risk to public health or public safety before making a final decision on the application.”
It’s not the first time Health Canada has sent notices to provincial colleges of physicians informing them of health care practitioners connected to numerous high gram-a-day authorizations. In 2020, the Saskatchewan College of Physicians and Surgeons levied a $15,000 disciplinary action against a Saskatchewan doctor found to be profiting from issuing medical cannabis licences in 2018.
In 2021, a medical cannabis patient who had been authorized 100 grams a day had a court reject an allowance for the patient to possess up to 1,000 grams in public at a time.
In a memo from October 2022, Health Canada said that since it began a new process to address high authorization amounts through the program, the agency had observed a decrease of more than 50% in the number of individuals registering to produce cannabis for medical purposes.
The memo continued that in September 2021, approximately 47,000 individuals registered with Health Canada. By September 30, 2022, the number of registered individuals had dropped to approximately 21,700. As of March 2024, it was 15,726, although numbers began to show an uptick after several years of decline.
The regulator has also refused or revoked over 1,400 registrations, including more than 700 for public health and safety reasons. This represents a 113% increase in refusals and revocations and a 423% increase in the number of refusals and revocations made on the grounds of public health and public safety since March 2022.
While 4,728 healthcare practitioners were associated with registrations made with federally licensed sellers in the previous twelve months, 1,105 were associated with active personal/designated production registrations.
Of those 1,015, there were 233 healthcare practitioners associated with authorizing amounts equal to or above 25 grams per day, and just ten who authorized amounts equal to or above 100 grams per day.
Most (78%) healthcare practitioners who authorized more than 25 grams a day were in BC or Ontario. All who authorized more than 100 grams a day were in BC and Ontario. An authorization of 100 grams a day would equate to a limit of 487 plants at any given time. Such licences can also be combined to up to four per location, meaning a designated grower with several authorizations could be growing hundreds or even thousands of cannabis plants with the potential to produce in the hundreds of kilograms of cannabis a year.
History is full of timeless texts, and wisdom that make us think about the world around us differently. Two of these, “The Art of War” by Sun Tzu and, the modern-day philosophy of agorism by Samuel Edward Konkin the third, may seem like they have nothing in common. But if you delve deeper, you’ll find that they’re more similar than one might think and that by combining the two we can not only learn and grow but become better agorists. Let’s listen to the ancient warrior Sun Tzu:
“Victorious warriors win first and then go to war, while defeated warriors go to war first and then seek to win.” (Sun Tzu, The Art of War)
The Battleground of Agorism
Today’s world is a battlefield for freedom, where government control and manipulation are normal. But agorism gives us a way to fight back without aggression. Instead of fighting a losing battle using politics and laws, agorists focus on building a free society through voluntary actions and underground markets. By understanding how Sun Tzu conquered his enemies in ancient times, we can apply that same knowledge to break free from government chains and build a beautiful world we’d like to see.
Undermining the Enemy
Sun Tzu said to use deception and surprise as weapons, and that’s exactly how agorists operate. “All warfare is based on deception… If you know the enemy and know yourself, you need not fear the result of a hundred battles.” (Sun Tzu, The Art of War). Agorists hide from the government’s snooping, with fake names, encrypted messaging, and secret deals. We wage secret warfare against their whole system by staying under the radar while we build a new, freer society.
Always Adapting
One key to ancient warfare was the ability to change and adapt, just like agorists have to in today’s world. “He who is able to adapt himself to changing conditions will live.” (Sun Tzu, The Art of War). As government control gets worse, agorists stay ahead of the game by inventing new ways to trade and live free. This could be through cryptocurrencies, growing our own food, or trading with each other in secret. The key is to never stop finding new ways to beat them at their own game.
Strength in Numbers
To win on the ancient battlefield, warriors had to work together. Agorists know that cooperation is just as important for our struggle! We have to band together and help each other. Build networks, create communities, and support those who share our fight for freedom. With more strength and unity the harder it’ll be for the government to put a stop to our progress.
Taking the High Ground
Knowing where you stand, just like in an ancient battle, is vital to achieving victory. “To secure ourselves against defeat lies in our own hands, but the opportunity of defeating the enemy is provided by the enemy himself.” (Sun Tzu, The Art of War). Agorists know their strengths, weaknesses, and most importantly, where the government is most vulnerable. By exploiting those weak spots and sticking to what we’re good at, we can slowly dismantle their control over our lives.
Morality Matters
Even though Sun Tzu was all about war, he knew morals mattered. And that’s the same for agorism. “Let your plans be dark and impenetrable as night, and when you move, let your actions be swift and merciless as the wind.” (Sun Tzu, The Art of War). Our fight isn’t based on greed; it’s about a world where everyone can live free and prosper. A world where we aren’t slaves to government and violence.
A Free Future Awaits
“The Art of War” teaches us about strategy, conflict, and how to beat the odds. And agorism is our way of applying that ancient wisdom to today’s world. As Sun Tzu said, “There has never been a superior man who did not first appear inferior.” (Sun Tzu, The Art of War). Remember, the fight for liberty is ongoing. But with cunning, cooperation, and an unyielding spirit, we are the ones destined for victory.
Brandon Aragon
Brandon A. Aragon is a leading figure in counter-economics and international agorism. Since 2002, he has been a passionate advocate for individual freedom and libertarian principles. As the founder of Agorist Nexus, Brandon has created a dynamic platform for like-minded individuals to engage in counter-economics and promote agorist ideals globally. With expertise in finance, counter-economics, technology, and individual sovereignty, he champions the use of cryptocurrency as a tool for financial freedom and resistance against centralized control. Through his writings, speeches, and activism, Brandon inspires others to embrace agorism as a pathway to true autonomy in an increasingly authoritarian world.
In the 21st century, wild fish are are being replaced with farmed fish, as livestock, in the aquaculture industry.
However, the growth of aquaculture has come at the expense of the environment and the health of the fish. This results in the potential for major disease problems and food safety issues, according to a 2022 article in Frontiers Immunology.
As livestock, fish succumb to the same synthetic treatments as other commercial livestock. According to MDPI, a member of the United Nations Global Compact, in the name of Sustainability: vaccines have a significant role in managing live stocks.
Vaccines have been applied as “preventive measures” in fish to reduce the chance of diseases such as rabies, as well as parasitic and bacterial pathogens, which occur as part of the commercial farming process. Rabies in fish? [That is another fish story for another time]. Meanwhile…
Salmon farms, consequently, are ideal incubators for parasites and infectious diseases that are then spread to adjacent farms and to wild fish. These outbreaks are impossible to quarantine; mass escapes from salmon farms and the normal flow of tides and currents spread diseases and parasites to other fish over very wide areas.
Even though fish are not of the animal kingdom, fish vaccines are delivered in the same way as warm-blooded animals. If we investigate all modes and vectors of disease transmission then we can also say that disease-causing pathogens may also be introduced through live-attenuated vaccines.
A vaccine contains an agent resembling a disease-inducing microorganism– a bacterium, virus or toxin – that activates the body’s immune system. A vaccine is essentially a pathogen-imposter. —Carrington College,
A Fish Story
Fish story: noun, an extravagant or incredible story
Barbara Jackson from Pixabay” width=”395″ height=”262″>The $20-billion-a-year farmed salmon industry is the world’s fastest growing food producer, and it has made farmed Atlantic salmon the most popular fish on dinner tables North America. But at what cost?
Untreated waste from excess feed, decomposing fish, excrement, and chemical residue forms a toxic stew that kills or drives away marine life for hundreds of yards.
The management of farmed fish includes antibiotics, probiotics, injectable vaccines, breeding maintenance, nano-based drugs, and edible vaccines, all with monitoring requirements. Of course, disease resistant mutant strains result from antibiotic treatments. Hence, the vaccine program. When it comes to drug use in global aquatic products:
Long-term use of chemical inputs not only increases pathogenic bacteria resistance but also damages the fish and aquaculture environments, resulting in drug residues in aquatic products.
Disaster in the Making
In 2021, 81,000 fish escaped from an open-pen fish farm in Norway. In 2023, thousands of fish escaped an Icelandic farm. Escapees have been found in at least 32 rivers across north-west Iceland, many covered in deadly sea lice, lethal to wild fish. Escapees also breed with wild fish to cause wild fish declines.
A 2012-2022 study determined that 865 million farmed salmon have died in mass die-offs in the last decade due to aquaculture practices and technologies.
It’s the same old fish story, replayed over and over. When any life form is placed in crowded unsanitary conditions, and genetically modified, it becomes a pre-medicated disaster, for generations to come.
You’d think cooking would destroy the parasites. But destroying the nematodes at 145 degrees is like cooking a burger well-done. – Harold McGee, Food and Cooking, 2016
[embedded content]
A Medley of Injectables
If you’ve ever had tetras in your aquarium, you have supported the Glofish industry of genetically modified fish injected with florescent dyes. Glofish are one symptom of an injectable aquaculture. If you are a Koi Hobbyist, you will be told to inject vaccines. Whether injected with dyes, dipped in chemicals, or tattooed, the fish have not given their permission to painfully modify their body. To reduce death by dyeing, simply avoid purchasing modified fish.
According to a review of aquaculture vaccine technologies, old technologies of killed and live-attenuated vaccines, are being replaced with a new generation of recombinant, synthetic peptides, mucosal vaccines, subunit, DNA and RNA vaccines, nanoparticle-based and plant based edible vaccines, reverse vaccinology, and monovalent and polyvalent vaccines.
Parasites in Farmed Fish
Farmed salmon are bred to grow fast in cages so crammed that they are rife with parasites and disease. The fish eat pellets of fishmeal, vegetables, and animal byproducts; they are doused regularly with pesticides and antibiotics. – Time Magazine, July 2022
Do not assume that just because the fish are vaccinated that parasites do not still live on or in their slippery bodies. Conditions of overcrowding and poor sanitation have always been indicators of disease and infection in farmed animals, even in organically-farmed pork. In this way, the spironucleosis parasite can infest farmed fish through the freshwater source in hatcheries:
The parasite has been detected in wild salmonids living in freshwater that is used as a water source for hatcheries, which therefore represents a potential source of infection that we must try to control. — Lill-Heidi Johansen, scientist and project manager at Nofima.
While parasites (in the larval stage) can be eaten in uncooked, or undercooked, unfrozen wild seafood, they are also present a human health hazard in cooked farmed fish.
Salmon farms harbor two especially virulent parasites: sea lice and kudoa (soft-flesh syndrome). Sea lice infestations have been reported by operators in Canada, Norway, Scotland, and Ireland. – Pure Salmon Campaign
If you dine only on wild caught fish, be aware that parasites found among wild caught species are the nematodes or roundworms: (Anisakis spp., Pseudoterranova spp., Eustrongylides spp. and Gnathostoma spp.), cestodes or tapeworms (Diphyllobothrium spp.) and trematodes or flukes (Chlonorchis sinensis, Opisthorchis spp., Heterophyes spp., Metagonimus spp., Nanophyetes salminicola and Paragonimus spp.).
The fish spend two to three years in open-net farms that contain up to a million salmon jammed into 10 or 12 cages, which extend 30 feet below the surface and are anchored to the seabed. The crowded cages are petri dishes for tiny parasites called sea lice. —Time Magazine, July 2022
Know Your Fish
Not long ago, wild Atlantic salmon were an abundant species, living free. Today, they are an endangered species, gone from most rivers in the U.S.. Claims made by farmers that their fish are sustainable and natural are deceptive. Most consumers rarely have enough information to go on.
Up to 85 percent of the salmon we eat is imported from farms along the coasts of Norway, Chile, Scotland, and Canada. Yet the Food and Drug Administration, which is responsible for food safety, pays scant attention to farmed salmon at a time when food-borne pathogens are on the increase. —Time Magazine, July 2020
Inspired by Small Business Saturday, I decided to shop for locally-made gifts this holiday season. Christmas markets are a great place to go as they promote local businesses and artisans using ethically sourced items. AtShipyards Christmas Market in North Vancouver, rows of tiny wooden cabins and Christmas tunes got this elf into the shopping spirit. You should head to your local market and take in everything it offers!
Why Shop Local Christmas Markets?
Shopping at a local Christmas market is the ultimate holiday activity!
Edible Delights
A ‘Buy BC’ logo on a product means it was grown, raised or made in the province. This became my north star as I browsed. Find out if your region uses a unique “local” logo. Christmas markets are not farmer’s markets, so don’t expect fresh zucchini, but that doesn’t mean there aren’t local food products. I found liqueur made from locally grown cranberries produced in the Fraser Valley. There were tisanes sourced from herbs grown on Vancouver Island, local honey (which always supports the pollinators) and cider made from heirloom apples grown on a 100-year-old orchard in B.C’s Okanagan Valley – the largest fruit-producing region of the province.
A Botanical Treasure Trove
I was surprised to learn that a study byLOCO BCsuggests a 10% shift in consumer spending towards independent businesses would generate 4.3 billion dollars annually for B.C.’s economy. The stats are similar everywhere, and a Christmas market is a treasure trove. Handmade candles were infused with calendula botanicals sourced from a local flower farm. I also found vendors selling essential oils distilled from local herbs and flowers that can be used as bath balms or in a diffuser.
Talking to Vendors
The holidays are the most lucrative time for local entrepreneurs eager to tell you about their goods. Talk to them and ask how they make and source products and what it takes to sell locally. Ask about their community support.SCORE fosters vibrant small business communities through mentoring and education. The organization reports that in the U.S., 75% of small business owners donate an average of 6% of their annual profits to local community charities. It’s so nice to make connections with artisans in your neighborhood!
Indeed, Christmas markets are generally more expensive than shopping at big box stores. Remember the craftsmanship and that every dollar spent locally has an economic impact up to 4.6 times higher than a dollar spent on non-local goods.
Help Promote Local
Many vendors at Christmas markets don’t have shops; be sure to ask for a business card or their social media information and follow them. I came home with a pile of business cards I will include with the gifts I bought and for future contact and purchases. It’s a great way to support them and the local economy.
Feel, Touch, Smell and Eat
Be ready for lots of hands-on experiences. I was invited to try on toques made from local lamb’s wool. I ate sugar cookies and candy and sipped mulled wine, liqueur, and tisanes. You don’t often have the chance to do these things in traditional stores! It was a wonderful social experience.
Festive Discoveries Await
Just as you would smell the flowers while walking through a garden, do the same at a Christmas market. You might be surprised at what you will discover. Who knew local cranberries could be made into a sweet, albeit tart and peppery-tasting, liqueur?
Tilray Brands, Inc. announced a new Holiday campaign highlighting a series of cannabis-infused beverages from two of its beverage brands, XMG and Mollo, and its JUICED XTREME Resin Infused Pre-rolls.
High Tide Inc. announced that its Canna Cabana retail cannabis store, located at 5921 Perth Street, Richmond, Ontario, will open on Saturday, December 14. This opening will mark High Tide’s 189th Canna Cabana-branded retail cannabis location in Canada and the 75th in Ontario.
A United States appeals court seemed inclined to reject claims made by several marijuana businesses in Massachusetts, which argued that federal laws prohibiting cannabis are no longer constitutional.
The businesses, represented by prominent attorney David Boies, contend that significant changes since the Supreme Court upheld federal marijuana laws in 2005 make the prohibition outdated. Currently, 38 states have legalized medical or recreational cannabis. Boies argued that Congress’s original intent to eliminate cannabis nationwide has shifted, citing legislation and policy changes that reflect a more lenient approach.
Despite his arguments, the judges appeared skeptical. Judge Julie Rikelman, appointed by President Joe Biden, emphasized that Congress still aims to regulate controlled substances, including cannabis, to manage both legal and illegal markets. “That has not changed,” she noted, suggesting that federal regulation remains a valid objective.
The lawsuit, initiated last year, involves Massachusetts-based Canna Provisions, a cannabis retailer; Gyasi Sellers, who operates a cannabis delivery service; Wiseacre Farm, a grower; and Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), a publicly traded multistate cannabis company. In July, Judge Mark Mastroianni, appointed by former President Barack Obama, dismissed their case, stating that only the Supreme Court could overturn its 2005 ruling.
In the 2005 ruling, the court held that Congress has the authority under the Commerce Clause to criminalize cannabis possession and use, even in states that legalize it for medical use under the CSA.
The plaintiffs argue that the 2005 rationale has been undermined by subsequent legal and policy developments. They cited a 2021 statement by Justice Clarence Thomas in which he questioned whether the reasoning behind the decision still holds.
Boies also highlighted congressional actions that reflect a changing approach to cannabis. In 2014, Congress prohibited the Justice Department from using federal funds to interfere with state medical cannabis programs. Additionally, in 2010, Congress allowed the use of medical cannabis in Washington, D.C. More recently, the DOJ moved to reclassify cannabis as a Schedule 3 substance, a less severe category than its current Schedule 1 status. A hearing on this potential reclassification is set for January 2025.
Despite these changes, Judge David Barron, another Obama appointee, expressed doubt that these legislative carve-outs indicate a complete shift in federal policy. He questioned how these isolated measures prove that the federal government has abandoned its stance, especially when the overarching prohibition on cannabis sales remains in effect.
This case, Canna Provisions Inc. vs. Garland, continues to highlight the tension between state-level legalization and federal prohibition, a conflict that has yet to be resolved.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
A new study has found that marijuana users with epilepsy typically spend fewer days in the hospital for epilepsy-related issues compared to people with epilepsy who didn’t use cannabis. Data from the study shows that epileptic individuals who used cannabis had an elevated epilepsy event capturability rate and reduced hospital stays.
Although medical and recreational marijuana is legal across dozens of states, research into the drug’s potential medical benefits is still in its infancy. Oliver Hoerth from Mayo Clinic’s Department of Neurology’s Division of Epilepsy says the researchers determined that they needed more information about how THC, the main psychoactive compound in marijuana, affected epilepsy patients under observation.
A few past studies found that cannabis may have some effect against epilepsy and seizures but further research is needed to truly understand the connection between cannabis, THC, and epilepsy. For the recent study, Hoerth and his Mayo Clinic colleagues analyzed how hospital admission, length of stay, and epilepsy-related event recording in the epilepsy monitoring unit (EMU) were affected by marijuana use among patients with epilepsy.
They used admissions data from 2023 that included 191 epileptic patients with 61 cannabis users and 130 non-users and conducted an event capturability analysis of 151 patients who were admitted to the Mayo Clinic epilepsy monitoring unit with 53 marijuana users and 98 non-users. An epilepsy event was captured in 44 of the users as well as 64 of the non-users.
The team’s analysis led to the discovery that marijuana users had a mean admission length of 3.2 days compared to 3.8 days for non-cannabis users. Furthermore, the event capturability rate for patients with epilepsy who used cannabis saw an 18.1% jump compared to non-users in the admissions database.
Study data also shows that cannabis users had a higher likelihood of possessing psychological condition-related epilepsy risk factors such as mental, sexual, and sexual abuse, generalized anxiety disorder, and major depressive disorder. This could be because several past studies have found cannabis can help manage mental disorders such as anxiety and depression. A growing number of Americans now use the drug for mental health reasons.
However, as cannabis research is still a vastly unexplored field, Hoerth and his colleagues at the Mayo Clinic noted that further study is necessary to truly understand the neuropsychological effects of cannabis use in individuals with epilepsy as well as how the drug affects overall brain health, mood disorders, and cognitive function.
When studies publish their findings indicating that marijuana use could reduce the amount of time epileptic patients spend in hospital, entities like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) are encouraged to keep bringing medical marijuana products to the market since their full direct and indirect positive effects are only beginning to be documented.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
Puslinch, Ontario – December 10, 2024 – Galaxie Brands, a leader in cannabis co-packing and automation, proudly announces the successful conclusion to the Companies Creditors Arrangement Act (CCAA) process, marking the start of a new exciting chapter.
Bolstered by strengthened partnerships, major new client relationships, and operational enhancements, Galaxie is well-positioned to redefine excellence in full-service co-manufacturing, covering cannabis packaging, manufacturing, storage and logistics.
In a significant step forward, Galaxie Brands has brought on large co-manufacturing clients to produce and pack pre-rolls for their flagship brands, with current production of several hundred thousand PRs per month, expected to increase in the coming months. This partnership underscored Galaxies’ reputation for delivering high-quality, automated co-packing solutions and highlights its commitment to working with industry leaders to bring best-in-class products to market.
Throughout the CCAA process, Galaxie not only maintained operations but achieved significant milestones, including deepening partnerships with TobaGrown/TobaRolling in Manitoba. Together, Galaxie provided the horsepower to TobaGrown’s presence in Manitoba, enabling an uninterrupted supply to the existing SKUs in-market at a winning price point. The companies continued forward, launching multiple successful products bolstering Galaxie’s portfolio and expanding TobaGrown’s presence in the MB market. These efforts include producing pre-rolls, sourcing premium flower, excising, and shipping products back to Manitoba. Continuing into December, TobaGrown will be launching a line of AIO vapes, infused pre-rolls and blunts, and an expanding line of edibles. The collaboration was pivotal in generating strong revenue and positioning both companies for sustained success.
With a focus on automation, cost efficiency, and client-first service, Galaxie specializes in pre-creation (standard, infused and coated), pre-roll packaging, flower packaging and edibles. The company’s state-of-the-art facility enables it to deliver industry-leading turnaround times and pricing, making it the preferred partner for cannabis producers across Canada.
Guiding Galaxies’ future is a new Chief Operating Officer, Richard Aranha, who has extensive experience in cannabis operation and supply chain management, and brings fresh energy to the company leadership. Formally with TGOD for six years and BZAM following the merger, Aranha held key roles such as Facilities Engineer, Supply Chain Director and Director of Continuous Improvement. His engineering background and deep understanding of the cannabis industry are instrumental in driving Galaxie’s automation strategy and operational excellence.
“Galaxie is the perfect launchpad for mid-sized companies across Canada, as is evidenced by the growth of TobaGrown portfolio and sales – with our very significant capacities, we are able to offer companies the ability to scale, enjoy low production costs and keep COGS at a minimum, avoid the challenges of having to manage fluctuating labour requirements, and to serve nearly every major market in Canada in all major product categories. Galaxie is positioned for turn-key services for brands of all sizes to be able to enter and grow in the market. Given our position as a service provider to so many brands, we find ourselves in the nexus of many different verticals – our scale enables efficiencies that we are determined to pass on to our customers to form an unbeatable overall ecosystem of value. I am privileged to lead the Galaxie team.” said Mr. Aranha.
Under Aranha’s leadership, Galaxie has implemented and streamlined processes, enhancing transparency and efficiency. These improvements reflect Galaxie’s commitment to providing the best quality and value in the industry.
As the company looks to the future, Galaxie is focused on building additional partnerships with licensed producers, expanding the market presence of brands it works with, and delivering innovative solutions tailored to its client’s needs. The company is poised to become Canada’s top choice for automated co-packing and manufacturing services.
About Galaxie Brands
Galaxie Brands is a licensed producer and copacker of cannabis and cannabis products, specializing in pre-roll creation, pre-roll packaging, and flower packaging. Operating from its advanced facility and Puslinch, Ontario, Galaxie is committed to providing unmatched quality, efficiency, and value to its partners across Canada.
For media and related inquires, contact Jeremy Bouvet, National Marketing Manager, Galaxie Brands: [email protected].
In the 21st century, wild fish are are being replaced with farmed fish, as livestock, in the aquaculture industry.
Barbara Jackson from Pixabay” width=”395″ height=”262″>The $20-billion-a-year farmed salmon industry is the world’s fastest growing food producer, and it has made farmed Atlantic salmon the most popular fish on dinner tables North America. But at what cost?
Do not assume that just because the fish are vaccinated that parasites do not still live on or in their slippery bodies. Conditions of overcrowding and poor sanitation have always been indicators of disease and infection in farmed animals, even in organically-farmed pork. In this way, the spironucleosis parasite can infest farmed fish through the freshwater source in hatcheries:
Not long ago, wild Atlantic salmon were an abundant species, living free. Today, they are an endangered species, gone from most rivers in the U.S.. Claims made by farmers that their fish are sustainable and natural are deceptive. Most consumers rarely have enough information to go on.
Recent Comments